Profit Kyun Gira Itna? (Reasons for Profit Drop)
Is 86% ki badi girti hui profit ka sabse bada reason hai lenalidomide naam ki ek important drug ki sales mein kami. Iske saath hi, company ko kuch one-off expenses bhi aaye hain, jinhone earnings par asar dala. Co-Chairman & MD, G V Prasad ne kaha ki market mein challenges hain, par branded business ki strong performance aur currency mein positive moves ne thodi help ki hai.
Aage Ka Plan Kya Hai? (Strategy for Future Growth)
Quarter ke numbers ke baad bhi, Dr Reddy's management future profitability par focus kar raha hai. Prasad ne bataya ki ek two-pronged strategy follow ki jayegi: pehle, cost savings se core business ko mazboot karna aur doosre, product portfolio ko optimize karna. Company biosimilars, consumer health, aur new drug development jaisi growth areas mein bhi invest kar rahi hai taaki long-term value badh sake aur margins improve hon.
Results aane ke baad, 12 May, 2025 ko Dr Reddy's ka share Bombay Stock Exchange par 0.75% neeche band hua, jo ₹1270.10 tha.
